Overview

Four hundred and sixty-seven thousand. That's how many serious adverse drug events were reported to the FDA between 1998 and 2005-including 80,880 deaths. The reporting system that captured those numbers undercounts by an estimated 94%. The actual numbers are larger. The system was not designed to find out how much larger. The Drugs traces the complete institutional arc of the American psychiatric pharmaceutical pipeline-from the billion-dollar blockbuster era through the black box warnings the market ignored, the off-label marketing campaigns that sold schizophrenia drugs for insomnia and anxiety, the $9.4 billion in DOJ settlements that changed nothing, the surveillance architecture that structurally undercounts harm, the polypharmacy cascade that combines drugs without combined evidence, the serotonin narrative that outlived its science, and the nursing home system that uses antipsychotics as chemical restraint on patients who cannot consent. Zyprexa generated over $60 billion. Abilify became the top-selling drug in America-not top-selling psychiatric drug, but top-selling drug, period. Five pharmaceutical companies paid $9.4 billion in federal settlements for illegal off-label marketing. No senior executive was criminally prosecuted. The Corporate Integrity Agreements expired. The prescribing continued. The CMS National Partnership reduced the nursing home antipsychotic rate from 23.9% to 14.3%. Unsupported schizophrenia diagnoses increased 194%. Anticonvulsant substitution rose from 28% to 40%. Total psychotropic drug use remained at 80%. The system designed to solve the problem created new ways to avoid solving it. This is not an anti-psychiatry book. SSRIs help people. Antipsychotics help people. The drugs documented in this investigation have a legitimate place in the treatment of mental illness. The institutional failure is not that the drugs exist. The institutional failure is the distance between what patients were told and what the evidence supported-and the decades it took for the institutions responsible for clinical guidance to close that distance. Every factual claim sourced to the system's own records-FDA filings, DOJ settlements, OIG audits, CMS quality measures, peer-reviewed literature, and the FAERS database the system itself maintains. Every scientific debate presented with both sides at full strength. No conspiracy endorsement. No partisan framing. No anti-medication advocacy. The evidence is the story. The reader is the jury. The Mental Health Files is an eight-book investigative nonfiction series examining the institutional failures of the American mental health system. Each book investigates a different dimension: the pharmaceutical pipeline, involuntary treatment, for-profit hospitals, the troubled-teen industry, preventable violence and suicide, the access crisis, pediatric prescribing, and the evidence-based alternatives the system has chosen not to adopt. Each book stands alone. Each is built on the system's own records. Where the evidence is clear, the books say so. Where it is contested, they present both sides. Where it is absent, they note the gap and move on. No conspiracy theories. No anti-psychiatry positioning. The documents are the story.

Full Product Details

9798255136827

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available